SAS Output

23-JAN-2018 6:10

LEUK ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1312-ALL, CD22+, REL/REF, Inotuzumab+CVP 1 Y 1 CVP + Inotuzumab dose level 1 38 5 0 0 0 0 0 06/13/2014 2 3
        2 CVP + Inotuzumab dose level 2   5 0 0 0 0 0      
        3 CVP + Inotuzumab dose level 3   11 0 0 0 0 0      
        4 CVP + Inotuzumab dose level 4   5 0 0 0 0 0      
        5 CVP + Inotuzumab dose level 5   11 6 1 0 0 0      
            37 6 1 0 0 0      
 
  S1318-ALL, Age 65+, Ph±, Blinatumomab 1 T 1 Induction: Ph- 44 31 17 3 0 0 0 06/30/2015 169 70
        2 Induction: Ph+/Ph-like   16 9 0 0 0 0      
            47 26 3 0 0 0      
 
    2 Y 3 Post-remission: Ph- 44 20 13 2 1 0 0 06/30/2015    
        4 Post-remission: Ph+/Ph-like   12 8 1 0 0 0      
            32 21 3 1 0 0      
 
    3 Y 5 Maintenance: Ph- 44 13 9 8 4 1 0 06/30/2015    
        6 Maintenance: Ph+/Ph-like   10 9 8 6 2 0      
            23 18 16 10 3 0      
 
  S0805-Ph+ ALL, Dasatinib/CVAD +/- BMT 1 N 1 Induction/Consolidation 94 97 0 0 0 0 0 08/25/2010 35 17
            97 0 0 0 0 0      
 
    2 Y 2 Vincristine/Pred/Dasatinib   22 0 0 0 0 0 08/25/2010    
            22 0 0 0 0 0      
 
    3 Y 3 Allo stem cell transplant 37 43 0 0 0 0 0 08/25/2010    
            43 0 0 0 0 0      
 
    4 Y 4 Dasatinib   42 0 0 0 0 0 08/25/2010    
            42 0 0 0 0 0      
 
Yes E1910-BCR-ABL-neg, B ALL, Blinatumomab 1 E Total Registrations   74 28 12 8 3 1 06/06/2014 149 81
            74 28 12 8 3 1      
 
  E2906-AML, Age 60+, Clo vs Dauno+Cy 1 E Total Registrations   75 0 0 0 0 0 08/06/2012 144 78
            75 0 0 0 0 0      
 
No E1910-BCR-ABL-neg, B ALL, Blinatumomab 0 E Total Registrations   103 38 19 11 4 2 06/06/2014 149 81
            103 38 19 11 4 2      
 
    2 E Total Registrations   46 17 7 2 1 0 06/06/2014    
            46 17 7 2 1 0      
 
    3 E Total Registrations   38 13 5 1 1 0 06/06/2014    
            38 13 5 1 1 0      
 
    4 E Total Registrations   17 3 3 2 0 0 06/06/2014    
            17 3 3 2 0 0      
 
  E2906-AML, Age 60+, Clo vs Dauno+Cy 0 E Total Registrations   19 0 0 0 0 0 08/06/2012 144 78
            19 0 0 0 0 0      
 
    2 E Total Registrations   21 0 0 0 0 0 08/06/2012    
            21 0 0 0 0 0      
 
    3 E Total Registrations   11 0 0 0 0 0 08/06/2012    
            11 0 0 0 0 0      
 
  NHLBIMDS-LEUK, National MDS Study 1 E Total Registrations   5 4 1 0 0 0 12/22/2016 253 103
            5 4 1 0 0 0      
 

23-JAN-2018 6:10

LEUK Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S1612 AML/MDS, Age 60+, Aza/Novel Therapeutics 1 Specimen Submission 22-Dec-17
  2 Randomization 22-Dec-17